The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients
- 1 December 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (6) , 2385-2391
- https://doi.org/10.1046/j.1523-1755.2001.00062.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cytokine gene polymorphisms predict acute graft rejection following renal transplantationKidney International, 1999
- ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphismsTransplant Immunology, 1999
- Influence of dialysis with polyamide vs haemophan haemodialysis on monokines and complement activation during a 4-month long-term studyNephrology Dialysis Transplantation, 1999
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Rapid activation of the complement system by cuprophane depends on complement component C4Kidney International, 1998
- AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTEREuropean Journal of Immunogenetics, 1997
- Interleukin-10 gene knock-out mice: a model of chronic inflammationClinical Immunology and Immunopathology, 1995
- Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failureAmerican Journal of Kidney Diseases, 1995
- Interleukin-10Annual Review of Immunology, 1993
- Gene expression of interleukin-1β during hemodialysisKidney International, 1993